The current approved protocol for seasonal malaria chemoprevention (SMC) in Chad targets children 3–59 months. However, coverage data suggest that SMC drugs are often incorrectly administered to children older than five. In parallel, there is a global discussion about extending the eligible age range of SMC to protect children up to 10. This study aimed to explore perceptions of the feasibility and acceptability of extending SMC to older children, and the barriers to the correct delivery of SMC to the current target age group.
This poster was presented at the 69th annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: ChadKeywords: Community delivery | Public health communications | Child and maternal health | Malaria | Maternal, neonatal and child health | Preventive treatments | Seasonal malaria chemoprevention | SDG3
« Back to Publications